News | November 23, 2023
AstraZeneca Pharma India receives permission to Import formulations of new drug for sale
The receipt of this permission paves way for the launch of Olaparib film coated tablets in India
The receipt of this permission paves way for the launch of Olaparib film coated tablets in India
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
Lack of technology transfer stands out as a formidable barrier
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
The company has posted net profit of Rs.978.93 crores for the 6 months period ended September 30, 2023
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Subscribe To Our Newsletter & Stay Updated
